Clinical Trial

Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 27, 2025 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
To assess the 1-week effects and safety of esketamine in combination with pregabalin and duloxetine to relieve pain in patients with postherpetic Neuralgia(PHN).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-20.
Status change: Not Yet Recruiting → Recruiting 2025-04-24
Trial Details
NCT Number NCT06896994
Lead Sponsor Beijing Tiantan Hospital
Collaborators: Beijing Xiaotangshan Hospital, The First Hospital of Fangshan District,Beijing, Beijing Ditan Hospital, Hengshui People's Hospital
Conditions Postherpetic Neuralgia
Enrollment 150 participants
Start Date 2025-04-01
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-27